BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16026266)

  • 1. Aldose reductase in diabetic microvascular complications.
    Chung SS; Chung SK
    Curr Drug Targets; 2005 Jun; 6(4):475-86. PubMed ID: 16026266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase / polyol inhibitors for diabetic retinopathy.
    Obrosova IG; Kador PF
    Curr Pharm Biotechnol; 2011 Mar; 12(3):373-85. PubMed ID: 20939801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.
    Gupta JK
    Curr Pharm Biotechnol; 2024; 25(9):1073-1081. PubMed ID: 37649296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of polyol pathway in pathogenesis of diabetic microangiopathy].
    Nakamura J
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():52-61. PubMed ID: 15999685
    [No Abstract]   [Full Text] [Related]  

  • 5. Aldose reductase inhibitors and diabetic complications.
    Tomlinson DR; Willars GB; Carrington AL
    Pharmacol Ther; 1992; 54(2):151-94. PubMed ID: 1438531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications.
    Demaine AG
    Curr Med Chem; 2003 Aug; 10(15):1389-98. PubMed ID: 12871136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase: a window to the treatment of diabetic complications?
    Crabbe MJ; Goode D
    Prog Retin Eye Res; 1998 Jul; 17(3):313-83. PubMed ID: 9695797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase and the role of the polyol pathway in diabetic nephropathy.
    Dunlop M
    Kidney Int Suppl; 2000 Sep; 77():S3-12. PubMed ID: 10997684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.
    Thakur S; Gupta SK; Ali V; Singh P; Verma M
    Arch Pharm Res; 2021 Jul; 44(7):655-667. PubMed ID: 34279787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Lightman S
    Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S; Buyukbingol E
    Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
    Boel E; Selmer J; Flodgaard HJ; Jensen T
    J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
    Lorenzi M
    Exp Diabetes Res; 2007; 2007():61038. PubMed ID: 18224243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive treatment of diabetic microangiopathy: blocking the pathogenic mechanisms].
    Guillausseau PJ
    Diabete Metab; 1994; 20(2 Pt 2):219-28. PubMed ID: 8001709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of aldose reductase in diabetic complications.
    Chung SS; Chung SK
    Curr Med Chem; 2003 Aug; 10(15):1375-87. PubMed ID: 12871135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.